R De Caterina

2.2k total citations
54 papers, 1.3k citations indexed

About

R De Caterina is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Surgery. According to data from OpenAlex, R De Caterina has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 10 papers in Physiology and 9 papers in Surgery. Recurrent topics in R De Caterina's work include Atrial Fibrillation Management and Outcomes (16 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). R De Caterina is often cited by papers focused on Atrial Fibrillation Management and Outcomes (16 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). R De Caterina collaborates with scholars based in Italy, Czechia and United States. R De Caterina's co-authors include Rosalinda Madonna, Marika Massaro, Filippo Crea, A Maseri, Sergio Chierchia, Carlo Patrono, Agostino Consoli, Assunta Pandolfi, Guido Lazzerini and Steen Husted and has published in prestigious journals such as Circulation, Blood and Journal of Applied Physiology.

In The Last Decade

R De Caterina

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R De Caterina Italy	17	720	238	215	192	185	54	1.3k
Juana Vallés Spain	19	608 0.8×	277 1.2×	275 1.3×	199 1.0×	244 1.3×	65	1.7k
J.A. Jakubowski United States	17	410 0.6×	183 0.8×	230 1.1×	213 1.1×	178 1.0×	32	1.3k
Paul C. Armstrong United Kingdom	23	543 0.8×	240 1.0×	219 1.0×	74 0.4×	234 1.3×	50	1.4k
Mustafa Gür Türkiye	22	593 0.8×	90 0.4×	272 1.3×	80 0.4×	146 0.8×	88	1.4k
Rossella Liani Italy	19	503 0.7×	105 0.4×	241 1.1×	140 0.7×	204 1.1×	37	1.2k
Chiara Cuccurullo Italy	16	430 0.6×	58 0.2×	255 1.2×	160 0.8×	280 1.5×	30	1.6k
Kei Yunoki Japan	16	441 0.6×	111 0.5×	243 1.1×	76 0.4×	133 0.7×	38	917
Thomas Hohlfeld Germany	26	1.3k 1.9×	395 1.7×	507 2.4×	182 0.9×	274 1.5×	97	2.2k
Giovanni M. Puddu Italy	21	386 0.5×	76 0.3×	235 1.1×	216 1.1×	415 2.2×	54	1.6k
A Strano Italy	16	627 0.9×	111 0.5×	414 1.9×	85 0.4×	96 0.5×	87	1.3k

Countries citing papers authored by R De Caterina

Since Specialization

Citations

This map shows the geographic impact of R De Caterina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R De Caterina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R De Caterina more than expected).

Fields of papers citing papers by R De Caterina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R De Caterina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R De Caterina. The network helps show where R De Caterina may publish in the future.

Co-authorship network of co-authors of R De Caterina

This figure shows the co-authorship network connecting the top 25 collaborators of R De Caterina. A scholar is included among the top collaborators of R De Caterina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R De Caterina. R De Caterina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madonna, Rosalinda, Stefania Moscato, Maria Concetta Cufaro, et al.. (2022). Empagliflozin alleviates diabetic cardiomyopathy via inhibiting excessive autophagy and adverse remodeling in type 1 diabetic mice. European Heart Journal. 43(Supplement_2). 2 indexed citations

Ameri, Pietro, Ladislav Pecen, Igor Diemberger, et al.. (2022). Two-year outcomes of patients with atrial fibrillation and heart failure: the ETNA-AF-Europe registry. European Heart Journal. 43(Supplement_2).

Siller‐Matula, Jolanta M., Martin Unverdorben, Yukihiro Koretsune, et al.. (2022). The real-world effectiveness and safety of edoxaban treatment in 27,333 Global ETNA-AF programme patients with and without a history of heart failure. European Heart Journal. 43(Supplement_2).

Bisaccia, Giandomenico, et al.. (2021). Cardiovascular morbidity and mortality related to non-alcoholic fatty liver disease: a systematic review and meta-analysis of prospective studies. European Heart Journal. 42(Supplement_1). 3 indexed citations

Donne, Maria Grazia Delle, et al.. (2020). Cardioprotective effect of Trimetazidine in patients with early breast cancer receiving anthracycline-based chemotherapy. European Heart Journal. 41(Supplement_2). 3 indexed citations

Koretsune, Yukihiro, Takeshi Yamashita, Young‐Hoon Kim, et al.. (2018). P1004The global ETNA-AF registry programme: snapshot baseline demographics and patient characteristics from more than 17,700 atrial fibrillation patients on edoxaban. European Heart Journal. 39(suppl_1).

Fedorowski, Artur, et al.. (2017). Hospital admissions for syncope and orthostatic hypotension predict incident cardiovascular disease in older middle-aged patients. Spiral (Imperial College London).

Madonna, Rosalinda, et al.. (2017). P699High glucose and hyperosmolar stress increase the expression of COX-2 and AQP1 in aorta of type 1 diabetic mice developing atherosclerosis: implication for unstable vascular disease in diabetes. European Heart Journal. 38(suppl_1). 1 indexed citations

Ling, Liang‐Han, Bernd Brüggenjürgen, Harald Darius, et al.. (2014). 44 * Sociodemographic and cardiovascular status but not anticoagulant choice independently predicts quality of life in patients with atrial fibrillation: results from the prefer in AF registry. EP Europace. 16(suppl 3). iii17–iii17. 1 indexed citations

10.

Halvorsen, Sigrun, Dan Atar, H. Yang, et al.. (2014). Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial. European Heart Journal. 35(28). 1864–1872. 262 indexed citations

11.

Massaro, Marika, Egeria Scoditti, Maria Antonietta Pellegrino, et al.. (2014). P617Peroxisome proliferator activated receptor(PPAR)alpha\gamma agonist aleglitazar reduces the inflammatory-mediated expression of monocyte chemoattractant protein(MCP)-1 selectively in human adipocytes. Cardiovascular Research. 103(suppl 1). S111.4–S111. 1 indexed citations

12.

Madonna, Rosalinda, et al.. (2010). NA+/H⁺ Exchanger 1-and Aquaporin-1-Dependent Hyperosmolarity Changes Decrease Nitric Oxide Production and Induce VCAM-1 Expression in Endothelial Cells Exposed to High Glucose. International Journal of Immunopathology and Pharmacology. 23(3). 755–765. 28 indexed citations

13.

Kuliczkowski, Wiktor, Adam Witkowski, Lech Poloński, et al.. (2008). Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. European Heart Journal. 30(4). 426–435. 175 indexed citations

14.

Madonna, Rosalinda, Marika Massaro, Assunta Pandolfi, Agostino Consoli, & R De Caterina. (2007). The Prominent Role of P38 Mitogen-Activated Protein Kinase in Insulin-Mediated Enhancement of VCAM-1 Expression in Endothelial Cells. International Journal of Immunopathology and Pharmacology. 20(3). 539–555. 29 indexed citations

15.

Caterina, R De & Rosalinda Madonna. (2004). Nutrients and Gene Expression. World review of nutrition and dietetics. 93. 99–133. 19 indexed citations

16.

Caterina, R De. (2001). Soluble e-selectin in essential hypertension: a correlate of vascular structural changes. American Journal of Hypertension. 14(3). 259–266. 52 indexed citations

17.

Bancalari, L, Ilaria Conti, Daniela Giannessi, et al.. (1999). Early increase in urinary leukotriene E₄ (LTE₄) is dependent on allergen dose inhaled during bronchial challenge in asthmatic subjects. Allergy. 54(12). 1278–1285. 10 indexed citations

18.

Basta, Giuseppina, Guido Lazzerini, S. M. Lenzi, et al.. (1997). 3.P.192 Early degrees of LDL oxidation induce VCAM-1 expression in cultured endothelial cells. Atherosclerosis. 134(1-2). 238–239. 2 indexed citations

19.

Ferrero, Maria Elena, Massimiliano Marco Corsi Romanelli, Luca Giovannini, et al.. (1997). Activity of resveratrol on endothelial adhesion molecules. CINECA IRIS Institutial research information system (University of Pisa). 19. 121–124. 3 indexed citations

20.

Caterina, R De, et al.. (1993). n-3 fatty acids and vascular disease : background and pathophysiology - hyperlipidaemia - renal diseases - ischaemic heart disease. Medical Entomology and Zoology. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact